HR 1188
116th Congress
House
Health
Business records
Drug safety, medical device, and laboratory regulation
Government information and archives
Health care costs and insurance
Inflation and prices
Licensing and registrations
Prescription drugs
FLAT Prices Act
Introduced: February 13, 2019
Introduced by:
Golden, Jared F.
Democratic
· Maine
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 14, 2019
Referred to the Subcommittee on Health.
Feb 13, 2019
Referred to the House Committee on Energy and Commerce.
Feb 13, 2019
Introduced in House
Plain-English summary
Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act
This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2